Teva Pharmaceutical (Israel) Financial Indicators Patterns

TEVA -- Israel Stock  

ILS 6,018  72.00  1.18%

We advise you to exercise Teva Pharmaceutical fundamental analysis to see if markets are presently mispricing the corporation. In other words this interface allows you to confirm available indicators of Teva Pharmaceutical as well as the relationship between them. . We found thirty-four available drivers for Teva Pharmaceutical Industries Limited which can be compared to its competition. To make sure the equity is not overpriced, please validate all Teva Pharmaceutical fundamentals including its Cash and Equivalents, Total Debt and the relationship between Net Income and Cash per Share . Use Teva Pharmaceutical to protect your portfolios against small markets fluctuations. The stock experiences somewhat bearish sentiment, but market may correct it shortly. Check odds of Teva Pharmaceutical to be traded at S5837.46 in 30 days.

Teva Pharmaceutical Company Summary

Teva Pharmaceutical competes with Tower Semiconductor, and Shufersal Ltd. Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel. Teva Pharmaceutical operates under Drug Manufacturers - Specialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 42535 people.

Teva Pharmaceutical Price to Book vs Return On Asset

Teva Pharmaceutical Industries Limited is currently regarded as top stock in price to book category among related companies. It is currently regarded as top stock in return on asset category among related companies reporting about  0.01  of Return On Asset per Price to Book. The ratio of Price to Book to Return On Asset for Teva Pharmaceutical Industries Limited is roughly  156.03 

Teva Pharmaceutical Systematic Risk

The output start index for this execution was five with a total number of output elements of thirty-four. The Beta measures systematic risk based on how returns on Teva Pharmaceutical correlated with the market. If Beta is less than 0 Teva Pharmaceutical generally moves in the opposite direction as compared to the market. If Teva Pharmaceutical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Teva Pharmaceutical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Teva Pharmaceutical is generally in the same direction as the market. If Beta > 1 Teva Pharmaceutical moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

Teva Pharmaceutical Industries Limited Total Assets Over Time

Distress Rating

Teva Pharmaceutical Financial Distress Probability

1%
Chance of Financial Distress
Teva Pharmaceutical Industries Limited has less than 1 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Teva Pharmaceutical Thematic Clasifications

Active Themes With Teva Pharmaceutical

Drugs Idea
DrugsView

Compare Teva Pharmaceutical

Compare Teva Pharmaceutical To Peers

Teva Pharmaceutical Opportunity Range

March 22, 2019 Opportunity Range

Also please take a look at World Market Map. Please also try Pattern Recognition module to use different pattern recognition models to time the market across multiple global exchanges.
Search macroaxis.com